↓ Skip to main content

High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
Published in
Journal of Experimental & Clinical Cancer Research, January 2022
DOI 10.1186/s13046-021-02214-z
Pubmed ID
Authors

Yuanyan Tang, Haisen Yin, Xinying Zhao, Dan Jin, Yan Liang, Tao Xiong, Lu Li, Wen Tang, Jiangzhao Zhang, Min Liu, Zhuojun Yu, Huimin Liu, Sibin Zang, Zhiping Huang

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 12%
Student > Master 5 10%
Student > Ph. D. Student 5 10%
Other 2 4%
Student > Bachelor 2 4%
Other 6 12%
Unknown 23 47%
Readers by discipline Count As %
Medicine and Dentistry 8 16%
Biochemistry, Genetics and Molecular Biology 6 12%
Immunology and Microbiology 3 6%
Unspecified 2 4%
Chemical Engineering 1 2%
Other 4 8%
Unknown 25 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2022.
All research outputs
#8,541,797
of 25,392,582 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#574
of 2,383 outputs
Outputs of similar age
#183,567
of 515,556 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#22
of 81 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,383 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,556 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.